Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...

Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, today announced that its scientific abstract, " Anti-14-3-3eta Autoantibodies: A Novel Diagnostic Biomarker that ...

ImmunoBrain, a clinical-stage biopharmaceutical company developing immunotherapies for neurodegenerative diseases, today announced the peer-reviewed publication in Nature Medicine of Phase 1b data ...

The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...

An experimental antibody designed to briefly block the immune checkpoint PD-L1 in the brain has cleared its first human ...

New data from the Phase 1b/2 trial of NOUS-209 in Lynch Syndrome (LS) carriers have been accepted for an oral presentation at the European ...

Spero Therapeutics gets a Buy on the immunology pivot, FDA-approved Utebzi, and $105M royalty deal funding SP001. Learn more ...

Shares of Xencor (XNCR) surged 17% on Friday, rising $2.52 to close at $17.47. The move came after the company announced a proffered paper oral presentation at ESMO 2026 for the Phase 1 clinical study ...

The American Kidney Fund (AKF) has launched an online course on lupus nephritis through its Kidney Health Coach® (KHC) program to educate community members and healthcare professionals about symptoms, ...

The California Applicant’s Attorneys Association Convention was held on January 29 through February 1, 2026, and as can be ...

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

July 16, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimm ...